Fully automated MRSA assay
The challenge to fight healthcare-associated infections in Europe is resulting in an increased number of active surveillance programmes for MRSA in a continually resource-constrained environment. Rapidly and accurately identifing methicillin-resistant Staphylococcus aureus (MRSA) in patients, the BD MAX MRSA assay enables infection control measures to be implemented faster, which can positively impact patient management. The fully automated, bench-top molecular system is designed to perform a broad range of molecular testing as well as the MRSA assay. This offers laboratory professionals the flexibility and versatility to perform CE/in vitro diagnostic assays and user defined protocols on the same platform.
Supplier: BD Diagnostics – Preanalytical Systems
Website:
